首选的尿剂治疗初级高血压: 甲基或甲酸?
1Trevor D. Young practices in outpatient internal medicine at Baylor Scott & White Health, Central Texas Region in Temple, Tex., and is an adjunct professor and clinical assistant professor in the University of Mary Hardin-Baylor Physician Assistant Program in Belton, Tex. The author has disclosed no potential conflicts of interest, financial or otherwise.
概括
建议在高血压治疗中使用chlorthalidone而不是hydrochlorothiazide,因为它能更好地减少主要心血管不良事件 (MACE). 这篇评论帮助临床医生根据最近的证据选择最佳的利尿剂.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 建议在初级高血压治疗中使用chlorthalidone,而不是hydrochlorothiazide,因为它能更好地减少主要心血管不良事件 (MACE).
- 尽管有建议,但甲仍然比甲更常见地被处方.
- 在指南建议和临床实践之间存在差异,关于高血压管理的利尿剂选择.
研究的目的:
- 审查最近的研究,比较chlorthalidone和hydrochlorothiazide在降低MACE中的有效性.
- 为临床医生提供基于证据的信息,以指导初级高血压的利尿剂选择.
- 为了弥补高血压推和处方利尿剂之间的差距.
主要方法:
- 对最近的临床研究进行系统审查.
- 对与甲和甲酸相关的MACE降低数据的分析.
- 对抗高血压利尿剂的比较有效性研究.
主要成果:
- 研究表明,与甲相比,甲对MACE的降低更大.
- 证据支持在高血压患者心血管风险降低中优先使用甲.
- 最近的研究证实了指导方针对利多的建议,而不是对利多的建议.
结论:
- 甲基是治疗初级高血压的首选利尿剂,因为它已被证明有效降低MACE.
- 临床医生应该考虑最近的证据有利于chlorthalidone优化心血管结果.
- 处方模式应与改善高血压管理和预防MACE的基于证据的建议保持一致.
相关概念视频
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
579
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
579
01:16Antihypertensive Drugs: Action of Diuretics
647
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
647
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
495
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
495
01:22Heart Failure Drugs: Diuretics
356
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
356
01:25Antihypertensive Drugs: Direct Renin Inhibitors
528
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
528
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
683
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
683